ジェノタイピングアッセイ市場：オファリング、テクノロジー、サンプルタイプ、アプリケーション、エンドユーザー別-2025-2030年世界予測

ジェノタイピングアッセイ市場は、2023年に179億3,000万米ドルと評価され、2024年には204億5,000万米ドルに達すると予測され、CAGR 14.42％で成長し、2030年には460億6,000万米ドルに達すると予測されています。

ジェノタイピング・アッセイは、ゲノミクスとバイオテクノロジーにおける重要なツールであり、遺伝的変異の分析に不可欠で、病気の素因、個別化医療の機会、農業革新などを明らかにすることができます。ジェノタイピング・アッセイの必要性は、遺伝子組成に関する詳細な洞察を提供し、診断アプリケーション、医薬品開発、精密農業を促進する能力に起因します。その用途は、がんや心血管障害などの疾患に対する感受性の特定を支援するヘルスケアや、作物の回復力や収量を促進する農業など多岐にわたる。医薬品、診断学、ニュートリゲノミクス、動物育種などの業界では、様々な最終用途のためにこれらのアッセイが広く利用されています。

主な成長要因としては、精密医療の進歩、個別化ヘルスケアに対する意識の高まり、農業バイオテクノロジーの革新などが挙げられます。医薬品開発パイプラインにおけるジェノタイピングの統合が進み、個人の遺伝子プロファイルに合わせて治療法を調整する上で重要な役割を果たすことが、市場の成長を後押ししています。次世代シーケンシング技術の強化や、より包括的なデータ解析のためのバイオインフォマティクスとの統合によるジェノタイピング・アッセイ市場の拡大が新たなビジネスチャンスであり、遺伝子データに特化したデータ解析ソリューションを革新する新興企業への道筋が生まれます。

しかし、高度なジェノタイピング技術に関連する高コスト、新興市場における認識不足、遺伝子データの機密性に関する倫理的懸念が市場成長の課題となっています。さらに、技術進歩のペースが速いため、研究開発への継続的な投資が必要であり、慎重な対応が必要な規制上のハードルにつながる可能性もあります。

技術革新のために、企業は先進国市場と新興国市場の両方に適した、費用対効果が高く携帯可能なジェノタイピング・プラットフォームの開発に注力することができます。また、AIと機械学習を組み合わせて遺伝子データ解析を合理化し、予測や解釈の効率と精度を向上させる学際的研究にも大きな可能性があります。ジェノタイピングアッセイ市場の性質は、急速な技術進歩に牽引される非常にダイナミックなものであり、プライバシー懸念への対応に積極的な姿勢で臨み、技術的シナジーを活用した戦略的パートナーシップを重視することで、膨大な成長機会を提供しています。

市場力学：急速に進化するジェノタイピングアッセイ市場の主要市場インサイトを公開

ジェノタイピングアッセイ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化医療に対する需要の高まり
  • 遺伝性疾患の有病率の増加
  • ジェノタイピング技術の研究開発の活発化
• 市場抑制要因
  • ジェノタイピング機器や検査の維持・運営にかかるコストの高さ
• 市場機会
  • ジェノタイピングアッセイとデジタルヘルスプラットフォームおよび電子カルテ（EHR）の統合
  • 利害関係者間の継続的な協力活動
• 市場の課題
  • 複雑な規制コンプライアンスとジェノタイピングアッセイに関連する倫理的配慮

ポーターの5つの力：ジェノタイピングアッセイ市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ジェノタイピングアッセイ市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ジェノタイピングアッセイ市場における外部からの影響の把握

外部マクロ環境要因は、ジェノタイピングアッセイ市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ジェノタイピングアッセイ市場における競合情勢の把握

ジェノタイピングアッセイ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスジェノタイピングアッセイ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ジェノタイピングアッセイ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ジェノタイピングアッセイ市場における成功への道筋を描く

ジェノタイピングアッセイ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個別化医療の需要の高まり
    • 遺伝性疾患の増加
    • 遺伝子型判定技術の研究開発活動の増加
  • 抑制要因
    • 遺伝子型判定装置と検査の維持および実行にかかる高コスト
  • 機会
    • 遺伝子型判定検査とデジタルヘルスプラットフォームおよび電子健康記録（EHR）の統合
    • 利害関係者間の継続的な協力活動
  • 課題
    • ジェノタイピングアッセイに関連する複雑な規制遵守と倫理的考慮
• 市場セグメンテーション分析
  • 提供内容：効率性と精度を確保するために調査室や病院で機器の使用が増加
  • 応用：農業における遺伝子型判定アッセイの利用拡大による農業生産量の向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ジェノタイピングアッセイ市場：提供別

• 機器
• 試薬とキット
• ソフトウェアとサービス

第7章 ジェノタイピングアッセイ市場：技術別

• マイクロアレイ解析
• 次世代シーケンシング
• ポリメラーゼ連鎖反応
• サンガーシーケンス

第8章 ジェノタイピングアッセイ市場サンプルタイプ別

• 血液サンプル
• 頬粘膜スワブ
• 唾液サンプル
• 組織サンプル

第9章 ジェノタイピングアッセイ市場：用途別

• 農業
• 動物遺伝学
• 診断と個別化医療
• 薬理ゲノム学

第10章 ジェノタイピングアッセイ市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 病院・クリニック
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのジェノタイピングアッセイ市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のジェノタイピングアッセイ市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのジェノタイピングアッセイ市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • BD、Healthiansと提携し、在宅診断の精度向上とインドでのサービス拡大を目指す
  • サーモフィッシャーサイエンティフィック、ゲノム調査と臨床診断に革命を起こすパンジェノミックスアレイを発売
• 戦略分析と提言

企業一覧

• 3CR Bioscience Ltd.
• Azenta Life Sciences
• Bio-Rad Laboratories, Inc.
• Chemagen Technologie GmbH
• Danaher Corporation
• Eurofins Scientific SE
• Grifols, S.A.
• Hoffmann-La Roche Ltd.
• Illumina, Inc.
• LGC Biosearch Technologies
• Mayo Clinic Laboratories
• NeoGenomics Laboratories, Inc.
• New England Biolabs, Inc.
• Novogene Co., Ltd.
• Oxford Nanopore Technologies PLC.
• Pacific Biosciences of California, Inc.
• Paragon Genomics, Inc.
• Promega Corporation
• QIAGEN GmbH
• Standard BioTools Inc.
• TAKARA BIO INC.
• Tecan Trading AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. GENOTYPING ASSAY MARKET RESEARCH PROCESS
• FIGURE 2. GENOTYPING ASSAY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENOTYPING ASSAY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENOTYPING ASSAY MARKET DYNAMICS
• TABLE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SALIVA SAMPLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TISSUE SAMPLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. CANADA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 48. CANADA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. CANADA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CANADA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CANADA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 70. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. CHINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 75. CHINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. CHINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. CHINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. CHINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. INDIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 80. INDIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 81. INDIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 82. INDIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. INDIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. JAPAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 95. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 100. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 115. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. THAILAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 125. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 136. DENMARK GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 141. EGYPT GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. FINLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 151. FRANCE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 156. GERMANY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 161. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. ITALY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. ITALY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. ITALY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 168. ITALY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. ITALY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 171. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 176. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 181. NORWAY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. POLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 186. POLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. POLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 188. POLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. POLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. QATAR GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 191. QATAR GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 192. QATAR GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 193. QATAR GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 194. QATAR GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 196. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 201. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 206. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 211. SPAIN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 216. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 221. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 226. TURKEY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 231. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 236. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 241. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

The Genotyping Assay Market was valued at USD 17.93 billion in 2023, expected to reach USD 20.45 billion in 2024, and is projected to grow at a CAGR of 14.42%, to USD 46.06 billion by 2030.

Genotyping assays are critical tools in genomics and biotechnology, essential for analyzing genetic variations that can reveal predispositions to diseases, personalized medicine opportunities, and agricultural innovations. The necessity of genotyping assays stems from their ability to provide detailed insights into genetic compositions, facilitating diagnostic applications, drug development, and precision agriculture. Their applications span across healthcare, where they assist in identifying susceptibilities to diseases like cancer and cardiovascular disorders, and in agriculture, promoting crop resilience and yield. Industries such as pharmaceuticals, diagnostics, nutrigenomics, and animal breeding utilize these assays extensively for varied end-use purposes.

Key growth influencers include advancements in precision medicine, rising awareness of personalized healthcare, and innovations in agricultural biotechnology. The increasing integration of genotyping in drug development pipelines and its critical role in tailoring therapies to individual genetic profiles propels market growth. Emerging opportunities lie in expanding the genotyping assays market through enhanced next-generation sequencing technologies and integration with bioinformatics for more comprehensive data analysis, creating pathways for startups to innovate in data analytics solutions tailored for genetic data.

However, market growth is challenged by high costs associated with advanced genotyping technologies, lack of awareness in emerging markets, and ethical concerns about genetic data confidentiality. Additionally, the fast-paced technological advancements necessitate continuous investment in R&D and may lead to regulatory hurdles that need careful navigation.

For innovation, businesses can focus on developing cost-effective and portable genotyping platforms suitable for both developed and emerging markets. There's also significant potential in interdisciplinary research, combining AI and machine learning to streamline genetic data analysis, improving the efficiency and accuracy of predictions and interpretations. The nature of the genotyping assay market is highly dynamic, driven by rapid technological advancements, and offers vast opportunities for growth with a proactive stance on addressing privacy concerns and an emphasis on strategic partnerships that leverage technological synergies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Assay Market

The Genotyping Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing demand for personalized medicine
  • Increasing prevalence of genetic disorders
  • Increased research and development activities in genotyping technologies
• Market Restraints
  • High costs associated with maintaining, and running genotyping equipment and tests
• Market Opportunities
  • Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
  • Ongoing collaborative activities between stakeholders
• Market Challenges
  • Complex regulatory compliances and ethical considerations associated with genotyping assay

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Assay Market

A detailed market share analysis in the Genotyping Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Assay Market

A strategic analysis of the Genotyping Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Assay Market, highlighting leading vendors and their innovative profiles. These include 3CR Bioscience Ltd., Azenta Life Sciences, Bio-Rad Laboratories, Inc., Chemagen Technologie GmbH, Danaher Corporation, Eurofins Scientific SE, Grifols, S.A., Hoffmann-La Roche Ltd., Illumina, Inc., LGC Biosearch Technologies, Mayo Clinic Laboratories, NeoGenomics Laboratories, Inc., New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Promega Corporation, QIAGEN GmbH, Standard BioTools Inc., TAKARA BIO INC., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Instruments, Reagents & Kits, and Software & Services.
• Based on Technology, market is studied across Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction, and Sanger Sequencing.
• Based on Sample Type, market is studied across Blood Sample, Buccal Swab, Saliva Sample, and Tissue Sample.
• Based on Application, market is studied across Agriculture, Animal Genetics, Diagnostics & Personalized Medicine, and Pharmacogenomics.
• Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing demand for personalized medicine
    • 5.1.1.2. Increasing prevalence of genetic disorders
    • 5.1.1.3. Increased research and development activities in genotyping technologies
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with maintaining, and running genotyping equipment and tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
    • 5.1.3.2. Ongoing collaborative activities between stakeholders
  • 5.1.4. Challenges
    • 5.1.4.1. Complex regulatory compliances and ethical considerations associated with genotyping assay
• 5.2. Market Segmentation Analysis
  • 5.2.1. Offering: Growing usage of instruments in research labs and hospitals for ensuring efficiency and precision
  • 5.2.2. Application: Increasing usage of genotyping assays in agriculture for enhancing agricultural yields
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genotyping Assay Market, by Offering

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Kits
• 6.4. Software & Services

7. Genotyping Assay Market, by Technology

• 7.1. Introduction
• 7.2. Microarray Analysis
• 7.3. Next-Generation Sequencing
• 7.4. Polymerase Chain Reaction
• 7.5. Sanger Sequencing

8. Genotyping Assay Market, by Sample Type

• 8.1. Introduction
• 8.2. Blood Sample
• 8.3. Buccal Swab
• 8.4. Saliva Sample
• 8.5. Tissue Sample

9. Genotyping Assay Market, by Application

• 9.1. Introduction
• 9.2. Agriculture
• 9.3. Animal Genetics
• 9.4. Diagnostics & Personalized Medicine
• 9.5. Pharmacogenomics

10. Genotyping Assay Market, by End-User

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Hospitals & Clinics
• 10.5. Pharmaceutical & Biotech Companies

11. Americas Genotyping Assay Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Genotyping Assay Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Genotyping Assay Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. BD Partners with Healthians to Boost Home Diagnostic Accuracy and Expand Services in India
  • 14.3.2. Thermo Fisher Scientific Launches Pangenomix Array to Revolutionize Genomic Research and Clinical Diagnostics
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 3CR Bioscience Ltd.
• 2. Azenta Life Sciences
• 3. Bio-Rad Laboratories, Inc.
• 4. Chemagen Technologie GmbH
• 5. Danaher Corporation
• 6. Eurofins Scientific SE
• 7. Grifols, S.A.
• 8. Hoffmann-La Roche Ltd.
• 9. Illumina, Inc.
• 10. LGC Biosearch Technologies
• 11. Mayo Clinic Laboratories
• 12. NeoGenomics Laboratories, Inc.
• 13. New England Biolabs, Inc.
• 14. Novogene Co., Ltd.
• 15. Oxford Nanopore Technologies PLC.
• 16. Pacific Biosciences of California, Inc.
• 17. Paragon Genomics, Inc.
• 18. Promega Corporation
• 19. QIAGEN GmbH
• 20. Standard BioTools Inc.
• 21. TAKARA BIO INC.
• 22. Tecan Trading AG
• 23. Thermo Fisher Scientific Inc.